| abstract |
Compounds, compositions and methods for modifying insulin secretion, particularly in connection with the treatment of subjects suffering from or suspected of having diabetes. The above compounds have the following structure (I): [Chemical 1] And (I) includes stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. In which W 1 , W 2 , X, R 1 , R 2 , R 3 , R 4 , m and n are defined herein. |